Gut Microbiotia, Probiotics and Their Impact Throughout the Lifespan
September 22, 2014
Boston
Click HERE to view or download a Program
Click HERE to view or download Speaker Biographies
Changes in the microbiota throughout the lifespan can have an important effect not only to treat symptoms and disease, but to impact disease prevention and health promotion. There has been a striking increase in immune-mediated inflammatory diseases in developed countries in recent years. This symposium will address this area as well as a wide range of emerging issues.
Click on a blue link to open the Webcast of that presentation in a new window.
Welcome
W. Allan Walker
Conrad Taff Professor of Nutrition & Pediatrics
Director, Division of Nutrition, Harvard Medical School
Director, Mucosal Immunology Laboratory, Massachusetts General Hospital
Opening Keynote: Manipulating the Microbiota: Beyond Traditional Probiotics and Fecal Transplant
R. Balfour Sartor, MD
Distinguished Professor of Medicine, Microbiology and Immunology; Director, UNC Multidisciplinary Center for IBD Research and Treatment, University of North Carolina
SESSION IA - PREGNANCY
Moderator: Mary Ellen Sanders, PhD
Dairy & Food Culture Technologies
Keynote: The Microbiota During Pregnancy
Omry Koren, PhD
Assistant Professor, Faculty of Medicine, Bar Ilan University, Israel
Probiotic Use During Pregnancy for Protection Against Childhood Diseases
Erika Isolauri, MD, D. Med. Sc
Professor of Pediatrics, University of Turku; Chief Physician, Department of Paediatrics, Turku University Hospital, Finland
Diet and Microbiotic Exposure During Pregnancy and Immune Protection Against Allergic Manifestations
Erika von Mutius, MD, MSc
Professor of Pediatrics, Head of Asthma and Allergy Department
Dr. von Hauner Children’s Hospital, Germany
SESSION IB - NEONATAL PERIOD
Moderator: W. Allan Walker, MD
Harvard Medical School
Keynote: Development of Human Infant Intestinal Microbiota
David A. Relman, MD
Thomas C. and Joan M. Merigan Professor, Departments of Medicine and of Microbiology and Immunology, Stanford University
Antibiotics and Neonatal Colonization
Martin J. Blaser, MD
Muriel and George Singer Professor of Medicine; Professor of Microbiology
Director, Human Microbiome Program, New York University Langone Medical Center
Establishment of a Milk-Oriented Microbiota in Infants: New Insight into Probiotics and Prebiotics
David A. Mills, PhD
Peter J. Shields Endowed Chair in Dairy Food Science, Department of Viticulture and Enology, Department of Food Science and Technology, University of California, Davis
W. Allan Walker, MD
Conrad Taff Professor of Nutrition; Professor of Pediatrics
Director, Division of Nutrition, Harvard Medical School, Mucosal Immunology and Biology Research Center, Massachusetts General Hospital
The Perinatal Microbiome: Implications for Health and Disease
Josef Neu, MD
Professor of Pediatrics, Division of Neonatology, University of Florida
SESSION II - ADULT PERIOD
Moderators: Peter R. Holt, MD, The Rockefeller University
and Richard L. Guerrant, MD, University of Virginia School of Medicine
Keynote: Diet and the Gut Microbiota
Gary D. Wu, MD
Ferdinand G. Weisbrod Professor of Gastroenterology; Associate Chief of Research, Division of Gastroenterology; Associate Director, Center for Molecular Studies in Digestive and Liver Disease, Perelman School of Medicine, University of Pennsylvania
Microbial Determination of Mucosal Homeostasis vs Chronic Intestinal Inflammation
R. Balfour Sartor, MD
Distinguised Professor of Medicine, Microbiology, and Immunology; Director, UNC Multidisciplinary Center for IBD Research and Treatment, University of North Carolina
Microbial Interventions for Obesity and Metabolic Syndrome
Max Nieuwdorp, MD, PhD
Associate Professor, Internal Medicine; Head of Experimental Vascular Medicine Department, Academic Medical Center, University of Amsterdam, Netherland; Visiting Professor, Gothenborg University, Sweden
Emeran A. Mayer, MD
Professor, Department of Medicine, Physiology and Psychiatry; Co-Director, CURE: Digestive Disease Research Center; David Geffen School of Medicine, University of California, Los Angeles; Executive Director, Oppenheimer Family Center for Neurobiology of Stress
Microbiome-gut-brain Interactions in an Autism Mouse Model
Elaine Y. Hsiao, PhD
Research Assistant Professor, Division of Biology & Biological Engineering, California Institute of Technology
SESSION III - OLDER ADULTS
Moderator: Samuel Klein, MD,
Washington University School of Medicine in St. Louis
Keynote: Microbiota in Older Adults– Changes, Associations, and Intervention Prospects
Paul W. O’Toole, PhD
Professor of Microbial Genomics. School of Microbiology & Alimentary Pharmabiotic Centre, University College Cork, Ireland
Probiotics and the Elderly Microbiome – Is it Ever Too Late to Change
Patricia L. Hibberd, MD, PhD
Professor, Department of Pediatrics, Harvard Medical School, Chief, Division of Global Health, Department of Pediatrics, Massachusetts General Hospital
Prevention of Recurrent Clostridium difficile Infection
Ciarán P. Kelly, MD
Professor of Medicine, Harvard Medical School; Director, Gastroenterology Fellowship Training; Medical Director, Celiac Center, Beth Israel Deaconess Medical Center
Diet, Microbiota and Atherosclerosis
Stanley L. Hazen, MD, PhD
Chair, Department of Cellular and Molecular Medicine; Vice Chair of Translational Research, Lerner Research Institute; Section Head of Preventive Cardiology & Cardiac Rehabilitation, Heart and Vascular Institute. Cleveland Clinic
Final Overview Keynote: Future Direction
Jonathan Braun, MD, PhD, Professor
Chair, Department of Pathology and Laboratory Medicine
David Geffen School of Medicine, University of California, Los Angeles
Closing Remarks
W. Allan Walker, MD